AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2008
Sep 11, 2008
30826_dirs_2008-09-11_0e8d13ff-bee0-4e0c-b2ce-c53d3c1345f8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2008-09-09
Reporting Person: RICH ALEXANDER (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-09-09 | Common Stock | M | 5000 | $1.28 | Acquired | 441500 | Direct |
| 2008-09-09 | Common Stock | S | 5000 | $5.05 | Disposed | 436500 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-09-09 | Common Stock Right to Buy | $1.28 | M | 5000 | Disposed | 2008-09-10 | Common Stock (5000) | Direct |
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23